140 related articles for article (PubMed ID: 23795784)
1. Comparison of prostate cancer diagnosis in patients receiving unrelated urological and non-urological cancer care.
Corcoran AT; Smaldone MC; Egleston BL; Simhan J; Ginzburg S; Morgan TM; Walton J; Chen DY; Viterbo R; Greenberg RE; Uzzo RG; Kutikov A
BJU Int; 2013 Jul; 112(2):161-8. PubMed ID: 23795784
[TBL] [Abstract][Full Text] [Related]
2. A population-based study of renal cell carcinoma and prostate cancer in the same patients.
Barocas DA; Rabbani F; Scherr DS; Vaughan ED
BJU Int; 2006 Jan; 97(1):33-6. PubMed ID: 16336324
[TBL] [Abstract][Full Text] [Related]
3. Local ablation vs partial nephrectomy in T1N0M0 renal cell carcinoma: An inverse probability of treatment weighting analysis.
Shi L; He Y; Liu C; Qian X; Wang Z
Cancer Med; 2020 Nov; 9(21):7988-8003. PubMed ID: 32888392
[TBL] [Abstract][Full Text] [Related]
4. The critical impact of tumor size in predicting cancer special survival for T3aM0M0 renal cell carcinoma: A proposal of an alternative T3aN0M0 stage.
Li L; Shi L; Zhang J; Fan Y; Li Q
Cancer Med; 2021 Jan; 10(2):605-614. PubMed ID: 33280246
[TBL] [Abstract][Full Text] [Related]
5. Renal cell carcinoma as a cause of end-stage renal disease in the United States: patient characteristics and survival.
Stiles KP; Moffatt MJ; Agodoa LY; Swanson SJ; Abbott KC
Kidney Int; 2003 Jul; 64(1):247-53. PubMed ID: 12787416
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysis.
Syed JS; Nguyen KA; Holford TR; Hofmann JN; Shuch B
Cancer; 2019 Jan; 125(2):232-238. PubMed ID: 30561791
[TBL] [Abstract][Full Text] [Related]
7. Extreme obesity does not predict poor cancer outcomes after surgery for renal cell cancer.
Blute ML; Zorn K; Grimes M; Shi F; Downs TM; Jarrard DF; Best SL; Richards K; Nakada SY; Abel EJ
BJU Int; 2016 Sep; 118(3):399-407. PubMed ID: 26589741
[TBL] [Abstract][Full Text] [Related]
8. Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.
Dess RT; Hartman HE; Mahal BA; Soni PD; Jackson WC; Cooperberg MR; Amling CL; Aronson WJ; Kane CJ; Terris MK; Zumsteg ZS; Butler S; Osborne JR; Morgan TM; Mehra R; Salami SS; Kishan AU; Wang C; Schaeffer EM; Roach M; Pisansky TM; Shipley WU; Freedland SJ; Sandler HM; Halabi S; Feng FY; Dignam JJ; Nguyen PL; Schipper MJ; Spratt DE
JAMA Oncol; 2019 Jul; 5(7):975-983. PubMed ID: 31120534
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell carcinoma (RCC).
Aizer AA; Urun Y; McKay RR; Kibel AS; Nguyen PL; Choueiri TK
BJU Int; 2014 May; 113(5b):E67-74. PubMed ID: 24053727
[TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study.
Xing M; Kokabi N; Zhang D; Ludwig JM; Kim HS
Radiology; 2018 Jul; 288(1):81-90. PubMed ID: 29737950
[TBL] [Abstract][Full Text] [Related]
11. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
Liu S; Feng C; Liu C; Wang Z
Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
[TBL] [Abstract][Full Text] [Related]
12. Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis.
Abhyankar N; Hoskins KF; Abern MR; Calip GS
BMC Cancer; 2017 Sep; 17(1):659. PubMed ID: 28946846
[TBL] [Abstract][Full Text] [Related]
13. Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database.
Lee C; Light A; Alaa A; Thurtle D; van der Schaar M; Gnanapragasam VJ
Lancet Digit Health; 2021 Mar; 3(3):e158-e165. PubMed ID: 33549512
[TBL] [Abstract][Full Text] [Related]
14. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma.
Morgan TM; Tang D; Stratton KL; Barocas DA; Anderson CB; Gregg JR; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
Eur Urol; 2011 Jun; 59(6):923-8. PubMed ID: 21295907
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological characteristics and outcomes of synchronous renal cell carcinoma and urothelial carcinoma: A population-based analysis.
Wu K; Liu X; Wang Y; Wang X; Li X
Front Public Health; 2022; 10():994351. PubMed ID: 36388369
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of end-stage renal disease in patients with renal cell carcinoma: a 12-year nationwide follow-up study.
Hung PH; Tsai HB; Hung KY; Muo CH; Chung MC; Chang CH; Chung CJ
Medicine (Baltimore); 2014 Aug; 93(8):e52. PubMed ID: 25121356
[TBL] [Abstract][Full Text] [Related]
17. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of laterality in renal cell carcinoma: A population-based study from the surveillance, epidemiology, and end results (SEER) database.
Guo S; Yao K; He X; Wu S; Ye Y; Chen J; Wu CL
Cancer Med; 2019 Sep; 8(12):5629-5637. PubMed ID: 31407495
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and Graft Survival of Kidney Transplant Recipients with Renal Cell Carcinoma.
Machhi R; Mandelbrot DA; Al-Qaoud T; Astor BC; Parajuli S
Am J Nephrol; 2020; 51(10):777-785. PubMed ID: 32998152
[TBL] [Abstract][Full Text] [Related]
20. The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.
Sun M; De Velasco G; Brastianos PK; Aizer AA; Martin A; Moreira R; Nguyen PL; Trinh QD; Choueiri TK
Eur Urol Focus; 2019 May; 5(3):474-481. PubMed ID: 29311016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
